Drug-labels.com

PMS-Nilotinib: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
150 mg, 200 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - PMS-Nilotinib

Serious warnings and precautions box

pms-NILOTINIB should be given under the supervision of a doctor experienced in the use of anti-cancer drugs. Serious side effects with pms-NILOTINIB include:

  • Sudden cardiac deaths,
  • Prolongation of the QT interval (abnormal electrical signal of the heart),
  • Ischemic heart disease (heart disorder), ischemic cerebrovascular events (stroke or other problems due to decreased blood flow to the brain) and peripheral arterial occlusive disease (PAOD) (problems with decreased blood flow to your leg), rare fatal cases have been reported,
  • Liver failure or liver toxicity (increase of liver enzymes), fatal cases have been reported,
  • Pancreatitis (inflammation of the pancreas),
  • Myelosuppression (decrease of the production of blood cells).

pms-NILOTINIB is not to be used in patients who have uncorrectable low levels of potassium or magnesium.

pms-NILOTINIB should only be stopped under the supervision of a doctor experienced in the treatment of patients with chronic myeloid leukemia (CML).

What pms-NILOTINIB is used for:

pms-NILOTINIB is used to treat adults with:

  • newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase,
  • chronic phase and accelerated phase Ph+ CML who are no longer benefiting from other therapies for CML including imatinib.

pms-NILOTINIB is used to treat children and adolescents 2 years of age and older with:

  • newly diagnosed Ph+ CML in chronic phase,
  • chronic phase Ph+ CML who are no longer benefiting from other therapies for CML including imatinib.

How pms-NILOTINIB works:

CML is caused by a change in your DNA (genetic material) that triggers a signal in your body to produce abnormal white blood cells. pms-NILOTINIB blocks this signal to stop making these abnormal cells.

The ingredients in pms-NILOTINIB are:

Medicinal ingredient: Nilotinib (as nilotinib hydrochloride dihydrate).

Non-medicinal ingredients: Carrageenan, colloidal silicon anhydrous, crospovidone, erythrosine (150 mg) hypromellose, iron oxide red (150 mg), iron oxide yellow, lactose monohydrate, magnesium stearate, potassium chloride, and titanium dioxide. Printing ink: iron oxide black, potassium hydroxide, propylene glycol and shellac.

pms-NILOTINIB comes in the following dosage forms:

Capsules: 150 mg or 200 mg nilotinib (as nilotinib hydrochloride dihydrate).

Do not use pms-NILOTINIB if:

  • You have a condition that causes an abnormal electrical signal in your heart (prolongation of QT interval).
  • You have uncorrectable low levels of potassium or magnesium.
  • You are allergic (hypersensitive) to nilotinib or any of the other ingredients of pms-NILOTINIB.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take pms-NILOTINIB. Talk about any health conditions or problems you may have, including if you:

  • have electrolyte problems (e.g., low blood potassium levels) or conditions that could lead to electrolyte disturbances (e.g., vomiting, diarrhea, dehydration),
  • have an eating disorder or are following a strict diet,
  • have diabetes, especially with associated nerve disorders,
  • had a stroke or other problems due to decreased blood flow to the brain,
  • have problems with decreased blood flow to your legs,
  • have liver/kidney disease,
  • have had pancreatitis (inflammation of the pancreas),
  • have had a surgical procedure involving the removal of the entire stomach (total gastrectomy),
  • have ever had or might now have a hepatitis B virus infection (a viral infection of the liver). This is because during treatment with pms-NILOTINIB, hepatitis B may become active again, which can be fatal in some cases. This is called hepatitis B reactivation. Your doctor will

    • check for signs of this infection before and during treatment with pms-NILOTINIB.

Other warnings you should know about:

Lactose Intolerance:

pms-NILOTINIB contains lactose. Tell your doctor if you have lactose intolerance or one of the following rare hereditary diseases:

  • Galactose intolerance
  • Lapp lactase deficiency
  • Glucose-galactose malabsorption.

Heart Conditions:

pms-NILOTINIB can cause sudden cardiac death or other serious heart conditions such as QTc prolongation. QTc prolongation causes an irregular heartbeat, which can be life threatening. These heart rhythm disturbances are more likely if:

  • you have a heart condition,
  • you have a family history of heart conditions, or
  • you are taking medicines that affect your heartbeat (antiarrhythmics), or medicines that may have an unwanted effect on the function of the heart (QT prolongation) (see also other drugs that may interact with pms-NILOTINIB under “INTERACTIONS WITH THIS MEDICATION”).

If you experience any symptoms of a possible heart rhythm disturbance, such as dizziness, palpitations (sensation of rapid, pounding, or irregular heartbeat), fainting, or seizures, you should seek immediate medical attention.

Growth and Development:

Children and adolescents may grow more slowly when taking pms-NILOTINIB. Your child’s doctor will measure

their growth at regular visits.

Medical Tests:

Before and during the treatment with pms-NILOTINIB, certain blood tests will be done. These will monitor how pms-NILOTINIB is affecting your body. Electrocardiograms (ECG) may also be done regularly. An ECG is a test that measures how well your heart is working.

Driving and Heavy Machinery:

pms-NILOTINIB may cause dizziness. DO NOT drive or use machines if you feel dizziness or are unable to see well while taking pms-NILOTINIB.

Reproductive Health:

Men who take pms-NILOTINIB must use highly effective birth control during treatment with pms-NILOTINIB, and for at least 4 weeks after ending treatment. Tell your doctor right away if your female partner becomes pregnant.

Pregnancy and Breastfeeding:

pms-NILOTINIB is not recommended during pregnancy as it may harm the fetus. Women who can get pregnant must use highly effective birth control during treatment with pms-NILOTINIB and for at least 4 weeks after ending treatment.

You should not breast feed while taking pms-NILOTINIB and for two weeks after the last dose.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following medicines may interact with pms-NILOTINIB, used to treat/or:

  • An HIV medicine called ritonavir;
  • Medicines used to treat asthma such as formoterol, salmeterol;
  • Medicines used to prevent blood clots called warfarin;
  • Medicines used to treat cancer such as imatinib, lapatinib, sunitinib, vorinostat;
  • Medicine used to treat dementia such as dihydroergotamine, ergotamine;
  • Medicines used to treat epilepsy such as carbamazepine, phenobarbital, phenytoin;
  • A medicine used to treat slow stomach emptying called domperidone;
  • An herbal medicine used to treat depression called St. John’s Wort;
  • A medicine used to treat high blood pressure or irregular heartbeat called verapamil;
  • Medicines used to lower cholesterol called statins (such as simvastatin, lovastatin);
  • Medicines used to treat bacterial or fungal infections such as cefazolin, ciprofloxacin, clarithromycin, erythromycin, fluconazole, itraconazole, ketoconazole, levofloxacin, moxifloxacin, rifampicin, telithromycin, voriconazole, amphotericin B, pentamidine;
  • Medicines used to treat irregular heartbeat such as amiodarone, digoxin, disopyramide, flecainide, ibutilide, procainamide, propafenone, quinidine, sotalol;
  • Medicines used to treat malaria such as chloroquine, halofantrine;
  • Medicines that can disturb electrolyte levels such as enemas, high dose corticosteroid, laxatives, water pills;
  • A medicine used to treat angina called bepridil;
  • Medicines used to treat depression and anxiety such as citalopram, fluoxetine, amitriptyline, imipramine, maprotiline, venlafaxine, midazolam;
  • Medicines used to treat nausea such as dolasetron, metoclopramide, ondansetron, prochlorperazine;
  • A medicine used to treat addiction called buprenorphine;
  • Medicines used to treat pain such as methadone, morphine, alfentanil, fentanyl;
  • Medicines used to prevent organ transplant rejection such as cyclosporine A, cyclosporine, sirolimus, tacrolimus;
  • Medicines to stabilize thinking and behaviour such as chlorpromazine, haloperidol, droperidol, pimozide, ziprasidone;
  • A medicine to treat low thyroid hormone called levothyroxine.

Taking pms-NILOTINIB with Antacids:

While taking pms-NILOTINIB, speak with your healthcare professional before taking antacids (medicines to treat heartburn). These medications need to be taken separately from pms-NILOTINIB:

  • antacids called H2 blockers which suppress the production of acid in the stomach – should be taken approximately 10 hours before or 2 hours after you take pms-NILOTINIB;
  • antacids such as those containing aluminum hydroxide, magnesium hydroxide and simethicone which neutralize the high acidity of the stomach – should be taken approximately 2 hours before or 2 hours after you take pms-NILOTINIB.

Taking pms-NILOTINIB with Food and Drink:

Do not take pms-NILOTINIB with food. Taking pms-NILOTINIB with food may increase the amount of pms-NILOTINIB in the blood, possibly to a harmful level.

Do not take any products or juices containing grapefruit, star fruit, pomegranate, Seville oranges or similar fruits while taking pms-NILOTINIB. This may increase the amount of pms-NILOTINIB in blood, possibly to a harmful level.

How to take pms-NILOTINIB:

  • Always take pms-NILOTINIB exactly as your healthcare professional has told you.
  • Your healthcare professional may lower your dose or stop treatment. This may be based on a specific blood test result or if you feel unwell.
  • If treatment with pms-NILOTINIB is stopped, your healthcare professional will continue to carefully monitor your CML. Your doctor may tell you to re-start pms-NILOTINIB if you require it.
  • Swallow capsules whole with water on an empty stomach. Do not consume any food for at least 2 hours before the dose is taken and for at least 1 hour after the dose is taken.

If capsules cannot be swallowed:

  • Open the capsules
  • Mix the content of each capsule in one teaspoon of applesauce (pureed apple) Use only one single teaspoon of applesauce (not more).

    Use only applesauce (no other food).

Swallow the mixture immediately.

Usual dose

Adults:

Newly diagnosed Ph+ CML in chronic phase:

  • Usual daily dose 600 mg: take two 150 mg capsules two times a day, approximately every 12 hours.
  • Reduced daily dose 400 mg: take two 200 mg capsules once a day.

Chronic phase and accelerated phase Ph+ CML in patients who are no longer benefitting from previous treatment for CML:

  • Usual daily dose 800 mg: take two 200 mg capsules two times a day, approximately every 12 hours.
  • Reduced daily dose 400 mg: take two 200 mg capsules once a day.

Children and adolescents:

  • Your child’s dose will depend on their body weight and height. The doctor will calculate the

    correct dose to use and tell you how many capsules of pms-NILOTINIB to give to your child.

  • Your child’s dose of pms-NILOTINIB may change as your child grows.

Pediatric dosing of pms-NILOTINIB

Total Daily DoseHow to take this dose
300 mg

Take one 150 mg capsule in the morning, and

Take one 150 mg capsule in the evening.

400 mg

Take one 200 mg capsule in the morning, and

Take one 200 mg capsule in the evening.

600 mg

Take two 150 mg capsules in the morning, and

Take two 150 mg capsules in the evening.

700 mg

Take one 200 mg capsule and one 150 mg capsule in the morning, and

Take one 200 mg capsule and one 150 mg capsule in the evening.

800 mg

Take two 200 mg capsules in the morning, and

Take two 200 mg capsules in the evening.

Overdose:

If you think you, or a person you are caring for, have taken too much pms-NILOTINIB contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed Dose:

If a dose is missed, take the next dose as scheduled. Do not take a double dose to make up for the forgotten capsules.

Possible side effects from using pms-NILOTINIB:

These are not all the possible side effects that you may have when taking pms-NILOTINIB. If you experience any side effects not listed here, tell your healthcare professional.

  • fatigue;
  • weakness;
  • muscle pain;
  • itching;
  • hair loss;
  • upper respiratory tract infections;
  • dyspepsia (digestion problems), eating disorder (anorexia), disturbed sense of taste;
  • skin reddening;
  • insomnia, depression, anxiety.

Call your doctor as soon as possible if you faint (loss of consciousness) or have an irregular heartbeat while taking pms-NILOTINIB as these may be due to a serious heart condition.

Serious side effects and what to do about them

Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
Only if severeIn all cases
Only if severeIn all cases
Only if severeIn all cases
Very common

Changes in blood test results:

Chills, fever, easy bruising, frequent infections, fatigue

✓
High levels of bilirubin in the blood: Yellow skin and eyes, pale stool, dark urine, loss of appetite, fatigue✓
Nausea✓
Common
Paresthesia: Sensation of tingling, pain or numbness in fingers and toes✓
Heart Disorders: Chest pain, or discomfort, high blood pressure, irregular heart rhythm blue discoloration of the lips, tongue or skin✓
Heart failure: Chest pain, irregular heart rhythm (fast or slow)✓
Prolongation of QT interval: Irregular heartbeat, fainting, loss of consciousness✓
Abdominal pain✓
Fever✓
Lung Disorders: Difficulty breathing or painful cough, wheezing with or without fever✓
Inflammation of the pancreas (pancreatitis): Severe upper (middle or left) abdominal pain✓
Growth Retardation: (when a child is not growing at a normal rate for their age)✓
Water retention: Rapid weight gain, swelling of hands, ankles, feet or face✓
High blood sugar: Excessive thirst, high urine output, increased appetite with weight loss, tiredness✓
Uncommon
Liver Damage: Yellow skin and eyes, nausea, loss of appetite, dark-colored urine✓
Diarrhea✓
Vomiting✓

Gastrointestinal disorders: Abdominal pain, nausea, vomiting of blood, black stools, constipation, heartburn, swelling

or bloating of the abdomen

✓
Blocked artery in leg, arm, finger or toe: pain or discomfort, weakness, or cramping in leg muscles which may be due to decreased blood flow, ulcers that heal slowly or not at all and noticeable changes in color (blueness or paleness) or temperature (coolness)✓
Generally feeling unwell✓
Bone pain✓
Pain in joints✓
Urinary tract disorders: Difficulty and pain when passing urine, exaggerated sense of needing to urinate, blood in urine✓
Overactive thyroid gland (hyperthyroid): Fast heartbeat, bulging eyes, weight loss, swelling at front of the neck✓
Low levels of growth hormone (growth hormone deficiency): growing more✓

slowly, short stature, weight gain especially around the body, changes in

muscle mass, changes in mood, delay in start of puberty

Migraine: Severe headache often accompanied by nausea, vomiting and sensitivity to light✓
Nervous system disorders (such as bleeding in the skull): Weakness or paralysis of limbs or face, difficulty speaking, severe headache, seeing, feeling or hearing things that are not there, loss of consciousness, confusion, disorientation, trembling✓
Kidney disorders (including kidney failure): Thirst, dry skin, irritability, dark urine, decreased urine output✓
Eye disorders: Blurred vision, loss of vision in eye, increased sensitivity of the eyes to light, eye pain or redness, swelling and itching of the eyelids, decreased sharpness of vision, eye irritation✓
Skin disorders: Rash, painful red lumps, pain in joints and muscles✓
Underactive thyroid gland (hypothyroid): Weight gain, tiredness, hair✓
Unknown
Rhabdomyolysis (breakdown of damaged muscle): Muscle spasms, fever, red- brown urine✓
Blood clot in a vein: Swelling and pain in one part of the body✓
Low blood pressure: Dizziness, spinning sensation✓
Second malignancies (such as gastric cancer, gastrointestinal stromal tumour, pancreatic carcinoma, pancreatic neuroendocrine tumour, colon cancer)✓
Tumour lysis syndrome (the sudden, rapid death of cancer cells due to the treatment): Nausea, shortness of breath, irregular heartbeat, clouding of urine, tiredness and/or joint pain✓
Hepatitis B reactivation (a previous viral infection of the liver becomes active again): fever, skin rash, joint pain and inflammation as well as tiredness, loss of appetite, nausea, jaundice (yellowing of the skin or whites of eyes), pain in the upper right abdomen, pale stools and dark urine. Hepatitis B reactivation can be fatal in some cases✓
Severe allergic reaction: Rash, hives, swelling of the face, lips tongue or throat, difficulty swallowing or breathing, dizziness✓
Cardiac tamponade: Anxiety, restlessness, chest pain✓
Bronchospasm: Difficulty breathing with wheezing or coughing✓
Abnormal laboratory values: Nausea, shortness of breath, irregular heartbeat, clouding of urine, tiredness and/or joint discomfort associated with blood test results (such as high potassium, uric acid, and phosphorous levels and low calcium levels in the blood)✓
Spontaneous abortions, stillbirth and fetal malformations.✓
Facial paralysis (weakness and paralysis of face muscles): loss of movement on one side of the face; drooping eye, drooping corner of the mouth, difficulty closing your eye, asymmetry of face✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting side effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Keep out of the reach and sight of children.
  • Store at 15 oC – 30oC, in the original package.

If you want more information about pms-NILOTINIB:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website (www.pharmascience.com), or by calling 1-888-550-6060.

Date of Authorization: October 23, 2026

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02564947

Approved according to the text: October 23, 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for PMS-Nilotinib

Rx or OTC
Prescription (Rx)?
DIN 02564947, 02565005
Schedule(s) PRESCRIPTION
Active ingredient(s) Nilotinib (nilotinib hydrochloride dihydrate)
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents
        1. L01EA BCR-ABL tyrosine kinase inhibitors
          1. L01EA03 Nilotinib
Company PHARMASCIENCE INC
Current status Approved
Current status date February 2, 2026
Strengths and forms
DIN Strength Dosage form(s) Current status
02564947 150 MG Capsule Approved February 2, 2026
02565005 200 MG Capsule Approved February 2, 2026

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.